Understanding off-target growth defects introduced to influenza A virus by synonymous recoding
C. P. Sharp, E. H. Thompson, B. Tesla, D. Kurian, P. Simmonds, P. Digard, E. R. Gaunt
Abstract
CpG dinucleotides are under-represented in the genomes of most RNA viruses. Synonymously increasing CpG content of a range of RNA viruses reliably causes replication defects due to the recognition of CpG motifs in RNA by cellular Zinc-finger Antiviral Protein (ZAP). Prior to the discovery of ZAP as a CpG sensor, we described an engineered influenza A virus (IAV) enriched for CpGs in segment 5 that displays the expected replication defects. However, we report here that this CpG-high ( CpGH) mutant is not attenuated by ZAP. To understand this, we sought to uncover the alternative attenuation mechanism(s). IAV segment 5 encodes NP, a component of the viral RNA replication complex. Unexpectedly, while CpG enrichment resulted in depleted segment 5 transcript and NP protein abundance, this did not impair viral polymerase activity. A pair of nucleotide changes, introduced as compensatory changes to maintain base frequencies, were instead found to be responsible for the replication defect. These mutations resulted in the encoding of a stretch of eight consecutive adenosines (8A), a phenomenon not seen in natural IAV isolates. Sequencing experiments revealed evidence of viral polymerase slippage at this site, resulting in the production of aberrant peptides and type I interferon induction. When the nucleotides in either of these two positions were restored to wildtype sequence, no viral attenuation was seen, despite the 86 extra CpGs encoded by this virus. Conversely, when these two adenosines were introduced into wildtype virus (thereby introducing the 8A tract), viral attenuation, polymerase slippage, aberrant peptide production and type I interferon induction were apparent. That a single nucleotide change can offset the growth defects in a virus designed to have a formidable barrier to wild-type reversion highlights the importance of understanding the processes underlying viral attenuation. The lessons from this study will inform improved recoding designs in the future.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategy
C. Sharp, B. H. Thompson, … E. R. Gaunt·bioRxiv·Apr 29, 2022
- Influenza A virus transcription generates capped cRNAs that activate RIG-I
Elizaveta Elshina, Emmanuelle M. Pitré, … Aartjan J.W. te Velthuis·bioRxiv·Nov 12, 2024
- NSUN2-dependent 5-methylcytosine Modification Regulates Influenza A virus Gene Expression and Genomic Packaging
Jing Hu, Shengqiang Jiang, … Hongying Chen·bioRxiv·Nov 26, 2025
- Association of zinc-finger antiviral protein (ZAP) binding to viral genomic RNA with attenuation of replication of echovirus 7
N. Goonawardane, D. Nguyen, P. Simmonds·bioRxiv·May 14, 2020
- Disruption of the polyuracil tract can greatly enhance immunostimulatory properties of influenza delVGs
Sydney NZ Jordan, Marisa Mendes, Alistair B. Russell·bioRxiv·Oct 16, 2026
- Replication competent, 10-segmented influenza viruses as antiviral therapeutics
G. D. Haas, A. T. Harding, N. S. Heaton·bioRxiv·Feb 11, 2019